BioSpace News Archive

Lumicell, Inc. announced that clinical data from a 234-patient, multi-center feasibility study of the Lumicell Direct Visualization System will be presented at the Society of Surgical Oncology’s International Conference on Surgical Cancer Care.

Palleon Pharmaceuticals today announced two poster presentations at the American Association for Cancer Research Annual Meeting in New Orleans, La., from April 8-13, 2022.

Wugen, Inc. today announced that management will present virtually at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022 at 4:00 p.m. ET.

Aspen Laser, LLC announced that research involving Aspen Laser, a Class IV laser therapy device, has been peer reviewed, accepted, and recently published in three medical journals: Photobiomodulation, Photomedicine, and Laser Surgery Journal, OBM Integrative and Complementary Medicine Journal, and The Journal of Lasers in Medical Sciences.

On February 21st, board-certified cardiologist, Dr. Vivek V. Kumar, completed 4 radial cases at Lakewood Ranch Medical Center in Florida using the Medical Ingenuities PH Band System.

9 Meters Biopharma, Inc. announced today that John Temperato, President & Chief Executive Officer of 9 Meters, will present at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022, at 10:00 a.m. (ET).

Artivion, Inc today announced that it will host an Investor & Analyst Day in New York City on Wednesday, March 23, 2022 at 9:00 AM ET.

Boundless Bio Announces Upcoming Presentation at the American Association for Cancer Research Annual Meeting 2022.

3D printed drugs have potential to revolutionize the personalized medicine sector. As the world moves toward the utilization of personalized medicines, market players and researchers across the world took strides toward utilizing 3D printing techniques.

Nurix Therapeutics, Inc., a biopharmaceutical company developing targeted protein modulation drugs, announced that Arthur T. Sands, M.D., Ph.D., Nurix’s president and chief executive officer, will participate in the following conferences in March:.